333 related articles for article (PubMed ID: 11525077)
1. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
Pereira H;
Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
[No Abstract] [Full Text] [Related]
2. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
Franzosi MG
Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
[No Abstract] [Full Text] [Related]
3. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
[TBL] [Abstract][Full Text] [Related]
4. Reperfusion in acute myocardial infarction: current concepts.
Katritsis D; Karvouni E; Webb-Peploe MM
Prog Cardiovasc Dis; 2003; 45(6):481-92. PubMed ID: 12800129
[TBL] [Abstract][Full Text] [Related]
5. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
[TBL] [Abstract][Full Text] [Related]
6. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
Patel VB; Moliterno DJ
J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
[No Abstract] [Full Text] [Related]
8. The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.
Sinno MC; Khanal S; Al-Mallah MH; Arida M; Weaver WD
Am Heart J; 2007 Apr; 153(4):579-86. PubMed ID: 17383297
[TBL] [Abstract][Full Text] [Related]
9. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Marino P
Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
[TBL] [Abstract][Full Text] [Related]
10. Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction.
Moliterno DJ; Topol EJ
Thromb Haemost; 1997 Jul; 78(1):214-9. PubMed ID: 9198156
[No Abstract] [Full Text] [Related]
11. Pharmacological reperfusion in acute myocardial infarction after ASSENT 3 and GUSTO V.
Ferreira D
Rev Port Cardiol; 2003; 22(7-8):1005-9. PubMed ID: 14587168
[No Abstract] [Full Text] [Related]
12. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.
Joseph A
J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258
[No Abstract] [Full Text] [Related]
13. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
Singh S; Gopal AK; Bahl VK
Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
[No Abstract] [Full Text] [Related]
14. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis.
Eccleston D; Topol EJ
Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017
[No Abstract] [Full Text] [Related]
15. Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
Lincoff AM
Rev Cardiovasc Med; 2002; 3 Suppl 1():S13-9. PubMed ID: 12439432
[TBL] [Abstract][Full Text] [Related]
16. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
Chew DP; Moliterno DJ; Herrmann HC
J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
[No Abstract] [Full Text] [Related]
17. [New strategies in the treatment of acute myocardial infarction].
Gonzi G; Ardissino D
Ital Heart J Suppl; 2001 Oct; 2(10):1055-60. PubMed ID: 11723606
[TBL] [Abstract][Full Text] [Related]
18. Primary angioplasty for acute myocardial infarction.
Gordon PC
Med Health R I; 2001 Feb; 84(2):44-50. PubMed ID: 11272659
[No Abstract] [Full Text] [Related]
19. Glycoprotein IIb/IIIa antagonists: an attractive new approach to reperfusion in acute myocardial infarction.
Gambhir DS
Indian Heart J; 1999; 51(3):259-60, 309. PubMed ID: 10624062
[No Abstract] [Full Text] [Related]
20. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
